H-DL-Thr-DL-Asn-DL-Pro-DL-Pro-DL-Ala-DL-Pro-DL-Thr-DL-Cys-DL-Thr-DL-aThr-NH2
| Internal ID | b7f32339-e18f-4dbe-b03a-5875a7e31c20 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 1-[1-[4-amino-2-[[(3R)-2-amino-3-hydroxybutanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]-N-[1-[2-[[(3R)-1-[[1-[[(3R)-1-[[(3S)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | CC(C(C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C)C(=O)N3CCCC3C(=O)NC(C(C)O)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)N)N)O |
| SMILES (Isomeric) | C[C@H](C(C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C)C(=O)N3CCCC3C(=O)NC([C@@H](C)O)C(=O)NC(CS)C(=O)NC([C@@H](C)O)C(=O)NC([C@H](C)O)C(=O)N)N)O |
| InChI | InChI=1S/C41H68N12O15S/c1-17(45-34(61)24-9-7-13-52(24)41(68)26-11-8-14-53(26)40(67)22(15-27(42)58)46-36(63)28(43)18(2)54)39(66)51-12-6-10-25(51)35(62)50-30(20(4)56)37(64)47-23(16-69)33(60)49-31(21(5)57)38(65)48-29(19(3)55)32(44)59/h17-26,28-31,54-57,69H,6-16,43H2,1-5H3,(H2,42,58)(H2,44,59)(H,45,61)(H,46,63)(H,47,64)(H,48,65)(H,49,60)(H,50,62)/t17?,18-,19+,20-,21-,22?,23?,24?,25?,26?,28?,29?,30?,31?/m1/s1 |
| InChI Key | DDANCFZIEHSLSJ-XYMUKPEBSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C41H68N12O15S |
| Molecular Weight | 1001.10 g/mol |
| Exact Mass | 1000.46478068 g/mol |
| Topological Polar Surface Area (TPSA) | 430.00 Ų |
| XlogP | -6.80 |
| Atomic LogP (AlogP) | -7.97 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 23 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6889 | 68.89% |
| Caco-2 | - | 0.8589 | 85.89% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.5143 | 51.43% |
| Subcellular localzation | Mitochondria | 0.5875 | 58.75% |
| OATP2B1 inhibitior | - | 0.8596 | 85.96% |
| OATP1B1 inhibitior | + | 0.8946 | 89.46% |
| OATP1B3 inhibitior | + | 0.9250 | 92.50% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.8606 | 86.06% |
| P-glycoprotein inhibitior | + | 0.7398 | 73.98% |
| P-glycoprotein substrate | + | 0.7583 | 75.83% |
| CYP3A4 substrate | + | 0.6680 | 66.80% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.7756 | 77.56% |
| CYP3A4 inhibition | - | 0.8286 | 82.86% |
| CYP2C9 inhibition | - | 0.9187 | 91.87% |
| CYP2C19 inhibition | - | 0.8738 | 87.38% |
| CYP2D6 inhibition | - | 0.9146 | 91.46% |
| CYP1A2 inhibition | - | 0.9161 | 91.61% |
| CYP2C8 inhibition | - | 0.6417 | 64.17% |
| CYP inhibitory promiscuity | - | 0.9713 | 97.13% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6031 | 60.31% |
| Eye corrosion | - | 0.9849 | 98.49% |
| Eye irritation | - | 0.8986 | 89.86% |
| Skin irritation | - | 0.7778 | 77.78% |
| Skin corrosion | - | 0.9159 | 91.59% |
| Ames mutagenesis | - | 0.6300 | 63.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3646 | 36.46% |
| Micronuclear | + | 0.7000 | 70.00% |
| Hepatotoxicity | + | 0.6782 | 67.82% |
| skin sensitisation | - | 0.8899 | 88.99% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.8444 | 84.44% |
| Mitochondrial toxicity | + | 0.7625 | 76.25% |
| Nephrotoxicity | - | 0.6610 | 66.10% |
| Acute Oral Toxicity (c) | III | 0.6481 | 64.81% |
| Estrogen receptor binding | + | 0.7905 | 79.05% |
| Androgen receptor binding | + | 0.6591 | 65.91% |
| Thyroid receptor binding | - | 0.4921 | 49.21% |
| Glucocorticoid receptor binding | - | 0.4672 | 46.72% |
| Aromatase binding | + | 0.7009 | 70.09% |
| PPAR gamma | + | 0.7586 | 75.86% |
| Honey bee toxicity | - | 0.8185 | 81.85% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.7400 | 74.00% |
| Fish aquatic toxicity | - | 0.8546 | 85.46% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.78% | 98.33% |
| CHEMBL2581 | P07339 | Cathepsin D | 98.26% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.22% | 96.09% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 97.65% | 89.63% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.39% | 88.42% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.15% | 98.24% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.94% | 100.00% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 95.76% | 92.38% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 95.66% | 95.52% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.44% | 93.10% |
| CHEMBL4801 | P29466 | Caspase-1 | 95.15% | 96.85% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 94.78% | 96.67% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 94.26% | 83.82% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.14% | 94.66% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.81% | 100.00% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.26% | 97.64% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 92.27% | 96.03% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 91.49% | 94.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 91.12% | 90.17% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.93% | 97.09% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 90.60% | 96.47% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 90.35% | 97.50% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 89.72% | 95.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.59% | 94.45% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.59% | 95.38% |
| CHEMBL204 | P00734 | Thrombin | 89.59% | 96.01% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 89.56% | 95.27% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 89.47% | 93.56% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.23% | 95.89% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 88.66% | 97.79% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 88.64% | 90.08% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 88.13% | 90.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 87.98% | 90.71% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 87.63% | 98.94% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 87.47% | 96.21% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 87.38% | 99.17% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 87.24% | 97.25% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 87.08% | 99.18% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 85.55% | 97.43% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 85.34% | 95.00% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 85.27% | 95.56% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 84.85% | 97.86% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 84.62% | 100.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 84.16% | 95.71% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.03% | 96.00% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 83.92% | 93.33% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 83.49% | 97.47% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.39% | 93.00% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 83.16% | 98.89% |
| CHEMBL5500 | Q92831 | Histone acetyltransferase PCAF | 82.98% | 91.96% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.88% | 91.03% |
| CHEMBL3468 | P55210 | Caspase-7 | 82.55% | 95.68% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 82.44% | 92.12% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 82.39% | 97.23% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 82.33% | 93.03% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 82.31% | 98.77% |
| CHEMBL5028 | O14672 | ADAM10 | 82.00% | 97.50% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 81.66% | 96.67% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 80.99% | 99.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 80.95% | 95.89% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 80.73% | 93.33% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 80.49% | 99.29% |
| CHEMBL301 | P24941 | Cyclin-dependent kinase 2 | 80.13% | 91.23% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139588371 |
| LOTUS | LTS0045706 |
| wikiData | Q104976180 |